Is adjuvant chemotherapy necessary in pT1N1 gastric cancer?

BACKGROUND: Due to a lack of consensus on adjuvant treatments for pT1N1 gastric cancer, surgeons face a dilemma when deciding treatments for patients with pT1N1 gastric cancer after gastrectomy. The objective of this study was to determine survival benefits of adjuvant chemotherapy and risk factors...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Hyun Beak, An, Ji Yeong, Lee, Seung Hyoung, Choi, Yoon Young, Kim, Jong Won, Sohn, Soo Sang, Noh, Sung Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401346/
https://www.ncbi.nlm.nih.gov/pubmed/28431518
http://dx.doi.org/10.1186/s12885-017-3265-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5401346/
https://www.ncbi.nlm.nih.gov/pubmed/28431518
http://dx.doi.org/10.1186/s12885-017-3265-x

Ejemplares similares